-
Product Insights
Plague - Drugs In Development, 2024
Empower your strategies with our Plague – Drugs In Development, 2024 report and make more profitable business decisions. Plague is an infection caused by the bacterium Yersinia pestis. The organism is transmitted to humans who are bitten by fleas that have fed on infected rodents, or when human handle infected animals. Symptoms include headache, fatigue or malaise, muscle aches, fever and chills, abdominal pain, diarrhea and vomiting, shock, and bleeding from the mouth, nose, ectum, or under the skin. Treatment includes...
-
Product Insights
Venezuelan Equine Encephalitis - Drugs In Development, 2024
Empower your strategies with our Venezuelan Equine Encephalitis – Drugs In Development, 2024 report and make more profitable business decisions. Venezuelan Equine Encephalitis is caused by a viral pathogen Venezuelan Equine Encephalitis Virus is a mosquito-borne disease that may progress to encephalitis. The mode of infection is by mosquitoes through an aerosol route or others where it enters the salivary glands and undergoes replication of viral cells. Patients are presented by flu-like symptoms that are mild and progresses to encephalitis causing...
-
Product Insights
West Nile Virus Infections - Drugs In Development, 2024
Empower your strategies with our West Nile Virus Infections – Drugs In Development, 2024 report and make more profitable business decisions. West Nile infection is caused by a virus transmitted by mosquitoes. The West Nile virus is a type of virus known as a Flavivirus. Symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. Risk factors for developing a more severe form of West Nile virus include conditions that weaken the immune system, such as HIV, organ...
-
Product Insights
Dermatomycoses - Drugs In Development, 2024
Empower your strategies with our Dermatomycoses – Drugs In Development, 2024 report and make more profitable business decisions. Dermatomycosis is the most common form of fungal infection of the skin and skin appendages. Areas such as the warm, humid areas of feet and spaces between toes, and armpits are often colonized by fungi. Dermatomycoses are mainly caused by filamentous fungi, which feed on the keratin present in skin, hair and nails. The Dermatomycoses drugs in development market research report provide comprehensive...
-
Product Insights
Equine Encephalitis - Drugs In Development, 2024
Empower your strategies with our Equine Encephalitis – Drugs In Development, 2024 report and make more profitable business decisions. Eastern Equine Encephalitis (EEE) is a rare but serious viral disease that affects humans and horses, caused by the Eastern Equine Encephalitis virus (EEEV), belonging to the Togaviridae family. The virus is primarily transmitted through the bite of infected mosquitoes, belonging to the Culiseta melanura species. The symptoms of EEE in humans can range from mild flu-like symptoms to more severe cases...
-
Product Insights
Helminthiasis (Parasitic Worm Infestation) - Drugs In Development, 2024
Empower your strategies with our Helminthiasis (Parasitic Worm Infestation) – Drugs In Development, 2024 report and make more profitable business decisions. Helminthiasis, also known as worm infection, is any macroparasitic disease of humans or other animals in which a part of the body is infected with parasitic worms, known as helminths. There are numerous species that are not necessarily related, and are broadly classified into tapeworms, flukes, and roundworms. They often live in the gastrointestinal tract of their hosts, but they...
-
Product Insights
Mumps - Drugs In Development, 2024
Empower your strategies with our Mumps – Drugs In Development, 2024 report and make more profitable business decisions. Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus that is spread from person to person by respiratory droplets (for example, when you sneeze) or by direct contact with items that have been contaminated with infected saliva. Symptoms include fever, face pain, headache, sore throat, swelling of the temples or jaw...
-
Product Insights
Onchocerciasis (River Blindness) - Drugs In Development, 2024
Empower your strategies with our Onchocerciasis (River Blindness) – Drugs In Development, 2024 report and make more profitable business decisions. Onchocerciasis, or river blindness, is a neglected tropical disease (NTD) caused by the parasitic worm Onchocerca volvulus. It is transmitted through repeated bites by blackflies of the genus Simulium. The disease is called river blindness because the blackfly that transmits the infection lives and breeds near fast flowing streams and rivers. The infection can result in visual impairment and sometimes blindness....
-
Product Insights
Rubulavirus Infections - Drugs In Development, 2024
Empower your strategies with our Rubulavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Mumps is a viral illness caused by a paramyxovirus, a member of the Rubulavirus family. The average incubation period for mumps is 16 to 18 days, with a range of 12 to 25 days. It is highly infectious and spreads rapidly among people living in close quarters. It is transmitted by respiratory droplets, direct contact, or contaminated objects. The Rubulavirus Infections drugs...
-
Product Insights
Systemic Aspergillosis - Drugs In Development, 2024
Empower your strategies with our Systemic Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an opportunistic infection that usually affects the lower respiratory tract and is caused by inhaling spores of the filamentous fungus Aspergillus, commonly present in the environment. The spores germinate and develop into hyphae, which enter blood vessels and, with invasive disease, cause hemorrhagic necrosis and infarction. Symptoms may be those of asthma, pneumonia, sinusitis, or rapidly progressing systemic illness. The...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.